The Clorox Company (NYSE:CLX - Free Report) - Analysts at Zacks Research decreased their Q2 2027 earnings per share (EPS) estimates for Clorox in a research note issued on Monday, November 16th. Zacks Research analyst Team now forecasts that the company will earn $1.02 per share for the quarter, down from their prior estimate of $1.30. Zacks Research currently has a "Strong Sell" rating on the stock. The consensus estimate for Clorox's current full-year earnings is $5.74 per share. Zacks Research also issued estimates for Clorox's FY2027 earnings at $5.71 EPS and FY2029 earnings at $6.20 EPS.
Several other equities analysts have also commented on the stock. Wall Street Zen raised shares of Clorox from a "sell" rating to a "hold" rating in a research report on Saturday, November 7th. Jefferies Financial Group lowered shares of Clorox from a "buy" rating to a "hold" rating and dropped their price objective for the company from $125.00 to $98.00 in a report on Tuesday, July 28th. Cantor Fitzgerald reissued an "overweight" rating on shares of Clorox in a research report on Tuesday, November 3rd. Citigroup reduced their target price on Clorox from $97.00 to $90.00 and set a "neutral" rating for the company in a research note on Wednesday, October 14th. Finally, Morgan Stanley boosted their price target on Clorox from $87.00 to $94.00 and gave the company an "equal weight" rating in a research note on Wednesday, November 4th. One analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Reduce" and an average target price of $93.79.
View Our Latest Research Report on Clorox
Clorox Price Performance
Shares of NYSE CLX opened at $106.62 on Wednesday. Clorox has a fifty-two week low of $79.12 and a fifty-two week high of $128.90. The company has a market cap of $12.92 billion, a PE ratio of 19.18, a P/E/G ratio of 3.49 and a beta of 0.59. The company has a debt-to-equity ratio of 32.91, a quick ratio of 0.39 and a current ratio of 0.65. The business has a 50-day simple moving average of $89.39 and a two-hundred day simple moving average of $99.53.
Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Monday, November 2nd. The company reported $1.55 earnings per share for the quarter, topping analysts' consensus estimates of $1.07 by $0.48. Clorox had a return on equity of 608.30% and a net margin of 9.41%. The firm had revenue of $1.91 billion during the quarter, compared to analysts' expectations of $1.88 billion. During the same quarter last year, the firm earned $0.85 EPS. The business's quarterly revenue was up 33.3% on a year-over-year basis.
Institutional Investors Weigh In On Clorox
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Empirical Finance LLC increased its holdings in Clorox by 0.9% during the 3rd quarter. Empirical Finance LLC now owns 11,313 shares of the company's stock worth $916,000 after purchasing an additional 96 shares during the period. Geneos Wealth Management Inc. lifted its holdings in shares of Clorox by 9.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,402 shares of the company's stock worth $145,000 after buying an additional 119 shares during the period. Elevation Wealth Partners LLC lifted its holdings in shares of Clorox by 32.3% in the 3rd quarter. Elevation Wealth Partners LLC now owns 565 shares of the company's stock worth $46,000 after buying an additional 138 shares during the period. Eastern Bank grew its position in shares of Clorox by 3.1% during the 3rd quarter. Eastern Bank now owns 5,052 shares of the company's stock worth $409,000 after buying an additional 150 shares in the last quarter. Finally, Mystic Asset Management Inc. grew its position in shares of Clorox by 1.3% during the 3rd quarter. Mystic Asset Management Inc. now owns 12,112 shares of the company's stock worth $981,000 after buying an additional 153 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company's stock.
Insider Activity
In related news, Director Pierre Breber bought 4,000 shares of the company's stock in a transaction that occurred on Wednesday, November 4th. The shares were purchased at an average cost of $100.06 per share, with a total value of $400,240.00. Following the completion of the acquisition, the director directly owned 22,000 shares in the company, valued at approximately $2,201,320. The trade was a 22.22% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.51% of the stock is currently owned by company insiders.
Clorox Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 12th. Shareholders of record on Wednesday, January 27th will be paid a dividend of $1.25 per share. The ex-dividend date is Wednesday, January 27th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 4.7%. Clorox's dividend payout ratio (DPR) is presently 89.93%.
Latest Clorox News
These are some of the CLX news items that stood out recently:
- Neutral Sentiment: Clorox declared its regular quarterly dividend of $1.25 per share, equivalent to $5.00 annually and a reported yield of 4.7%. The payout may appeal to income-focused investors, but no increase was announced. Clorox Declares Regular Quarterly Dividend of $1.25 Per Share
- Neutral Sentiment: Clorox Purell ProCare introduced new healthcare disinfecting wipes and dispensing technology. The launches expand its product lineup, though the report did not provide sales or earnings expectations. Clorox Purell ProCare Unveils Healthcare Surface Innovations
- Negative Sentiment: Zacks Research lowered its Q2 FY2027 EPS estimate to $1.02 from $1.30 and its FY2029 estimate to $6.20 from $6.89. It also cut its FY2028 forecast to $6.01 from $6.23 and reduced several quarterly projections. The breadth of the cuts, alongside its “Strong Sell” rating, is the clearest negative catalyst in the news.
About Clorox
(
Get Free Report)
The Clorox Company is a consumer products company founded in 1913 and headquartered in Oakland, California. It makes and markets products for household cleaning, food, water filtration, personal care and pet care. Its portfolio includes Clorox disinfecting and cleaning products, Glad trash bags and food-storage products, Kingsford charcoal, Brita water filters, Hidden Valley dressings and sauces, Burt's Bees personal-care products, and Fresh Step cat litter. The company also sells products under brands such as Pine-Sol and Liquid-Plumr.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.